NDC 0409-3532

PEMETREXED

Pemetrexed

PEMETREXED is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Pemetrexed Disodium.

Product ID0409-3532_c3938f61-1af2-4c1b-9a0c-2d31e217997d
NDC0409-3532
Product TypeHuman Prescription Drug
Proprietary NamePEMETREXED
Generic NamePemetrexed
Dosage FormInjection, Solution, Concentrate
Route of AdministrationINTRAVENOUS
Marketing Start Date2022-06-27
Marketing CategoryNDA /
Application NumberNDA214218
Labeler NameHospira, Inc.
Substance NamePEMETREXED DISODIUM
Active Ingredient Strength1 g/40mL
Pharm ClassesFolate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0409-3532-01

1 VIAL, SINGLE-DOSE in 1 CARTON (0409-3532-01) > 40 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2022-06-27
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "PEMETREXED" or generic name "Pemetrexed"

NDCBrand NameGeneric Name
0338-0720PEMETREXEDPEMETREXED
0338-0722PEMETREXEDPEMETREXED
0409-1045PEMETREXEDPEMETREXED
0409-1060PemetrexedPemetrexed
0409-1061PemetrexedPemetrexed
0409-1062PemetrexedPemetrexed
0409-2188PEMETREXEDPEMETREXED
0409-3532PEMETREXEDPEMETREXED
0480-4514PemetrexedPemetrexed
0480-4515PemetrexedPemetrexed
0480-4516PemetrexedPemetrexed
0781-3518PemetrexedPemetrexed disodium
0781-3519PemetrexedPemetrexed disodium
0781-3520PemetrexedPemetrexed disodium
16729-229PemetrexedPemetrexed
16729-230PemetrexedPemetrexed
16729-244PemetrexedPemetrexed
16729-522PemetrexedPemetrexed disodium
50742-340PemetrexedPemetrexed disodium
50742-341PemetrexedPemetrexed disodium
55150-381PemetrexedPemetrexed
55150-382PemetrexedPemetrexed
42367-531Pemfexypemetrexed
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.